Earnings History Data for Codiak BioSciences, Inc. (CDAK) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Codiak BioSciences, Inc.

Codiak BioSciences Inc. is a clinical-stage biopharmaceutical company. It is focused on development of exosome-based therapeutics for spanning oncology, neuro-oncology, neurology, neuromuscular disease and infectious disease. Codiak BioSciences Inc. is based in CAMBRIDGE, Mass.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
10-03-2022	AH		CDAK	Codiak BioSciences	97.00	-0.75	-1.03	0.00	Codiak BioSciences GAAP EPS of $0.74, revenue of $7.7M [3/10/2022 5:25 PM]	4.50	0.12 (2.74%)	4.70	0.32 (7.31%)	4.12 - 27.09	132,822	140,000	245
Codiak BioSciences GAAP EPS of $0.74, revenue of $7.7M [3/10/2022 5:25 PM] Codiak BioSciences rises 7% post-market after revenue soars 383% YoY [3/10/2022 5:58 PM] Codiak BioSciences Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Operational Progress [Mar-10-22 04:01PM] Codiak BioSciences, Inc. (CDAK) Reports Q4 Loss, Tops Revenue Estimates [Mar-10-22 05:15PM]
04-11-2021	AH		CDAK	Codiak BioSciences	340.00	-0.97	-0.95	0.00	Codiak BioSciences EPS misses by $0.03, misses on revenue [11/4/2021 5:20 PM]	16.56	1.59 (10.62%)	14.97	0.0 (0.00%)	7.90 - 37.85	91,423	40,000	138
Codiak BioSciences EPS misses by $0.03, misses on revenue [11/4/2021 5:20 PM] Codiak BioSciences Reports Third Quarter 2021 Financial Results and Recent Operational Progress [Nov-04-21 04:01PM] Codiak BioSciences, Inc. (CDAK) Reports Q3 Loss, Misses Revenue Estimates [Nov-04-21 05:15PM]
06-05-2021	AH	After the close (May 6)	CDAK	Codiak Biosciences, Inc.	440.00	-0.51	-1.01	0.00	Codiak BioSciences EPS beats by $0.47, beats on revenue [5/6/2021 5:02 PM]	18.45	0.18 (0.99%)	18.25	-0.02 (-0.11%)	7.90 - 37.85	108,159	280,000	450
Codiak BioSciences EPS beats by $0.47, beats on revenue [5/6/2021 5:02 PM] Codiak BioSciences Reports First Quarter 2021 Financial Results and Operational Progress [May-06-21 04:01PM]
17-03-2021	PM		CDAK	Codiak BioSciences, Inc.	363.93	-1.14	-1.11	0.00	Codiak BioSciences EPS beats by $0.07, beats on revenue [3/17/2021 7:54 AM]	17.82	-0.24 (-1.33%)	0.0	0.0 (0.00%)	7.90 - 37.85	58,978	120,000	0
Codiak BioSciences EPS beats by $0.07, beats on revenue [3/17/2021 7:54 AM] Codiak BioSciences Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Progress [Mar-17-21 07:30AM]